Mucopolysaccharidosis II Market 2022-2028: Industry Analysis, Trends, Growth, Opportunities, and Forecast

The Mucopolysaccharidosis II Market size is expected to grow at an annual average of 5% during 2022-2028. Mucopolysaccharide II (MPS II)/Hunter syndrome is a congenital disorder that causes complications in carbohydrate metabolism. The first individual with X-linked mucopolysaccharidosis (MPS) was first reported in 1917 by a clinician named Hunter. Hunter syndrome is known to occur almost exclusively in men and is characterized by distinctive facial features such as swollen lips, a large head, large, round cheeks, a broad nose, and an enlarged tongue (magnolia). Mucopolysaccharide II (MPS II)/Hunter syndrome is caused by a mutation in the iduronate 2-sulfatase (IDS) gene and is inherited in an X-linked fashion. Hunter’s syndrome is a complex debilitating disease that causes various anatomical and physiological anomalies with increasing age.

The following segmentation are covered in this report:

By Application

• Hospital
• Clinic
• Research Center

By Type

• JR-141
• EGT-301
• DUOC-01
• AGT-182
• JR-032

Company Profile

• Alexion Pharmaceuticals, Inc.
• AngioChem Inc.
• ArmaGen Inc.
• Bioasis Technologies Inc.
• Green Cross Corporation
• Inventiva
• JCR Pharmaceuticals Co., Ltd.
• Laboratorios Del Dr. Esteve S.A.
• RegenxBio Inc.
• Sangamo BioSciences, Inc.

Scope of the report

The research study analyses the Mucopolysaccharidosis II Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Mucopolysaccharidosis II Market Report

• What was the Mucopolysaccharidosis II Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Mucopolysaccharidosis II Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.